株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生物学的安全性試験の世界市場 〜2022年:製品、試験タイプ (エンドドキシン試験、無菌試験、細胞株認証、バイオバーデン試験)、用途・地域別

Biologics Safety Testing Market by Product (Instruments, Services, Kits & Reagents), Test (Endotoxin, Sterility Test, Cell Line Authentication, Bioburden), Application (Vaccine Development, Blood Products, Stem Cell Research) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 328907
出版日 ページ情報 英文 142 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.47円で換算しております。
Back to Top
生物学的安全性試験の世界市場 〜2022年:製品、試験タイプ (エンドドキシン試験、無菌試験、細胞株認証、バイオバーデン試験)、用途・地域別 Biologics Safety Testing Market by Product (Instruments, Services, Kits & Reagents), Test (Endotoxin, Sterility Test, Cell Line Authentication, Bioburden), Application (Vaccine Development, Blood Products, Stem Cell Research) - Global Forecast to 2022
出版日: 2017年07月18日 ページ情報: 英文 142 Pages
概要

生物学的安全性試験の世界市場は、12.2%の複合年間成長率 (CAGR)で2017年には27億5000万米ドル、2022年には49億米ドル規模に拡大することが見込まれています。政府支援による製薬・バイオテクノロジー企業の成長や、生命科学産業における研究開発の拡張、新薬の増加などが当市場の主な促進要因となっています。

当レポートでは、生物学的安全性試験の世界市場を調査し、製品 & サービス・試験タイプ・用途・地域別の市場動向、市場規模・成長率の推移と今後の予測、市場促進要因ならびに市場の機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 生物学的安全性試験:市場概要
  • 生物学的安全性試験の地域市場:製品・サービス別
  • 生物学的安全性試験の地域市場:概略
  • 生物学的安全性試験市場:用途別

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進因子
    • 機会
    • 課題

第6章 生物学的安全性試験市場:製品・サービス別

  • イントロダクション
  • 試験キット & 試薬
  • サービス
  • 器具

第7章 生物学的安全性試験市場:試験タイプ別

  • エンドトキシン試験
  • 無菌試験
  • 細胞株認証・特性試験
  • バイオバーデン試験
  • 残留汚染物質検出試験
  • 外来性汚染生物検出試験
  • その他

第8章 生物学的安全性試験市場:用途別

  • イントロダクション
  • ワクチン・治療薬開発
  • 血液・血液製剤試験
  • 細胞・遺伝子治療
  • 細胞・細胞加工製品試験
  • 幹細胞研究

第9章 生物学的安全性試験:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他の地域
    • 南米・中米・カリブ海地域
    • オセアニア
    • アフリカ

第10章 競合情勢

  • 概要
  • 競合ベンチマーキング
    • 製品ポートフォリオ
    • 事業戦略
  • 市場シェアの分析

第11章 企業プロファイル

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • MERCK KGAA
  • LONZA GROUP LTD.
  • SGS S.A.
  • THERMO FISHER SCIENTIFIC INC.
  • WUXI APPTEC
  • SARTORIUS AG
  • CYTOVANCE BIOLOGICS, INC.
  • PACE ANALYTICAL SERVICES INC.
  • TOXIKON CORPORATION
  • EUROFINS SCIENTIFIC SE
  • AVANCE BIOSCIENCES INC.
  • SOURCE BIOSCIENCE

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 3334

"The biologics safety testing market was valued at USD 2.75 billion in 2017 and expected to grow at a CAGR of 12.2% to a USD 4.90 billion market by 2022."

Growth in pharmaceutical and biotechnology industry driven by government support, the positive trend of R&D investment in the life science industry, and an increase in the number of new drug launches are factors driving the growth of this market. On the other hand, the time-consuming approval process for new drugs is considered a restraint for the market.

"Kits & reagents segment is expected to register the highest CAGR during the forecast period"

The biologics safety testing market is classified on the basis of product & service into kits & reagents, services, and instruments. The kits & reagents segment is expected to register highest growth rate during the forecast period. This growth can be attributed to the reoccurring purchase of kits & reagents, which is required for running tests.

"Endotoxin tests segment is accounted for largest share in the market"

The biologics safety testing market is classified by test type into endotoxin tests, sterility tests, cell line authentification and characterization tests, residual host contamination detection tests, adventitious agent detection tests, bioburden tests, and other tests. The endotoxin tests segment is expected to register the highest growth rate during the forecast period. This growth can be attributed to the increase in the number of drug launches.

"Increase initiative for immunization, increase company investment in vaccines development drives growth of the vaccines and therapeutics development segment"

By application, the biologics safety testing market is segmented into vaccine and therapeutics development; blood and blood-related products testing; cellular and gene therapy; tissue and tissue-related products testing; and stem cell research. The vaccine and therapeutics development segment are expected to register highest CAGR during the forecast period. The growth in this segment primarily attributed to initiatives for immunization and increased company investment in the development of vaccines.

"North America is account for the largest regional segment in the market"

Geographically, the biologics safety testing market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share of the market in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region, a strong trend in R&D in life science industry and an increase in drug approvals.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 43%, Tier 2 - 14% and Tier 3 - 43%
  • By Designation - C level - 14%, Director level - 43%, Others - 43%
  • By Region - North America - 29%, Europe - 14%, APAC - 43%, RoW - 14%

Key players operating in the biologics safety testing market include Lonza Group LTD. (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany), SGS SA (Switzerland), WuXi Apptec (China), Thermo Fisher Scientific Inc. (U.S.), Sartorius AG (Germany), Cytovance Biologics, Inc. (U.S.), Pace Analytical Services Inc. (U.S.), and Toxikon Corporation (U.S.).

Study Coverage:

The report analyses the biologics safety testing market by product & service, test type, applications, and regions. Apart from comprehensive geographic and product & service analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The market research data, market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

  • Market Penetration: The report analyzes the biologics safety testing market by product & service, test type and application
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the biologics safety testing market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various biologics safety testing product & service across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biologics safety testing market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. RESEARCH DATA
    • 2.2.1. SECONDARY SOURCES
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY SOURCES
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Breakdown of primary interviews
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BIOLOGICS SAFETY TESTING: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE (2017)
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE BIOLOGICS SAFETY TESTING MARKET
  • 4.4. BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION 2017 VS 2022

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growth in pharmaceutical and biotechnology industries driven by government support
      • 5.2.1.2. Positive trend of R&D investments in life science
      • 5.2.1.3. Increase in number of drug launches
      • 5.2.1.4. High incidence and large economic burden of chronic diseases
    • 5.2.2. OPPORTUNITIES
      • 5.2.2.1. Emerging Markets
      • 5.2.2.2. Increasing pharmaceutical outsourcing
    • 5.2.3. CHALLENGE
      • 5.2.3.1. Dearth of skilled professionals

6. BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. KITS & REAGENTS
  • 6.3. SERVICES
  • 6.4. INSTRUMENTS

7. BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE

  • 7.1. INTRODUCTION
  • 7.2. ENDOTOXIN TESTS
  • 7.3. STERILITY TESTS
  • 7.4. CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS
  • 7.5. BIOBURDEN TESTS
  • 7.6. RESIDUAL HOST CONTAMINANT DETECTION TESTS
  • 7.7. ADVENTITIOUS AGENT DETECTION TESTS
  • 7.8. OTHER TESTS

8. BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. VACCINE & THERAPEUTICS DEVELOPMENT
  • 8.3. BLOOD AND BLOOD-RELATED PRODUCTS TESTING
  • 8.4. CELLULAR AND GENE THERAPY
  • 8.5. TISSUE AND TISSUE-RELATED PRODUCTS TESTING
  • 8.6. STEM CELL RESEARCH

9. BIOLOGICS SAFETY TESTING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. U.K.
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE (ROE)
  • 9.4. ASIA
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA
  • 9.5. REST OF THE WORLD
    • 9.5.1. SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN
    • 9.5.2. PACIFIC AND OCEANIA
    • 9.5.3. AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
    • 10.1.1. VISIONARY LEADERS
    • 10.1.2. INNOVATORS
    • 10.1.3. DYNAMIC DIFFERENTIATORS
    • 10.1.4. EMERGING COMPANIES
  • 10.2. COMPETITIVE BENCHMARKING
    • 10.2.1. STRENGTH OF PRODUCT PORTFOLIO
    • 10.2.2. BUSINESS STRATEGY EXCELLENCE
  • 10.3. MARKET SHARE ANALYSIS

Top 25 companies analyzed for this studies are - Sartorius AG (Germany), SGS SA (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), Lonza Group LTD (Switzerland), Charles River Laboratories, Inc. (U.S.), Merck KGaA (Germany), Eurofins Scientific SE (Luxembourg), Source BioScience (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Cytovance Biologics (U.S.), Toxikon Corporation (U.S.), Avance Biosciences Inc. (U.S.), Pace Analytical Services LLC. (U.S.), WuXi Apptec (China), BioMerieux SA (France), Sterigenics International LLC (U.S.), Clean Cells (France), BSL Bioservice Scientific Laboratories Munich GmbH (Germany), North American Science Associates Inc. (U.S.), PromoCell GmbH (Germany), GenScript (China), Gibraltar Laboratories (U.S.), InvivoGen (U.S.), Neopharm Labs Inc. (Canada), ViruSure GmbH (Austria)

11. COMPANY PROFILES *(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*

  • 11.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 11.2. MERCK KGAA
  • 11.3. LONZA GROUP LTD.
  • 11.4. SGS S.A.
  • 11.5. THERMO FISHER SCIENTIFIC INC.
  • 11.6. WUXI APPTEC
  • 11.7. SARTORIUS AG
  • 11.8. CYTOVANCE BIOLOGICS, INC.
  • 11.9. PACE ANALYTICAL SERVICES INC.
  • 11.10. TOXIKON CORPORATION
  • 11.11. EUROFINS SCIENTIFIC SE
  • 11.12. AVANCE BIOSCIENCES INC.
  • 11.13. SOURCE BIOSCIENCE

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: BIOLOGICS SAFETY TESTING MARKET SUMMARY
  • TABLE 2: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022 (USD MILLION)
  • TABLE 3: BIOLOGICS SAFETY TESTING KITS AND REAGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: BIOLOGICS SAFETY TESTING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: BIOLOGICS SAFETY TESTING INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 7: ENDOTOXIN TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: STERILITY TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: BIOBURDEN TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: RESIDUAL HOST CONTAMINANT DETECTION TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: ADVENTITIOUS AGENT DETECTION TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: OTHER BIOLOGICS SAFETY TESTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 15: BIOLOGICS SAFETY TESTING MARKET FOR VACCINE AND THERAPEUTICS DEVELOPMENT, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: BIOLOGICS SAFETY TESTING MARKET FOR BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: BIOLOGICS SAFETY TESTING MARKET FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: BIOLOGICS SAFETY TESTING MARKET FOR TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: BIOLOGICS SAFETY TESTING MARKET FOR STEM CELL RESEARCH, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: BIOLOGICS SAFETY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 25: U.S.: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 26: U.S.: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 27: CANADA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 28: CANADA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 29: EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 31: EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 32: EUROPE: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 33: GERMANY: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 34: GERMANY: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 35: U.K.: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 36: U.K.: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 37: FRANCE: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 38: FRANCE: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 39: ITALY: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 40: ITALY: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 41: SPAIN: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 42: SPAIN: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 43: ROE: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: ROE: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 45: ASIA: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: ASIA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 47: ASIA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 48: ASIA: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 49: CHINA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 50: CHINA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 51: JAPAN: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: JAPAN: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 53: INDIA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 54: INDIA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 55: REST OF ASIA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: REST OF ASIA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 57: ROW: BIOLOGICS SAFETY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 58: ROW: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 59: ROW: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 60: ROW: BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: SOUTH AMERICA, CENTRAL AMERICA, & THE CARIBBEAN: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 62: SOUTH AMERICA, CENTRAL AMERICA, & THE CARIBBEAN: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 63: PACIFIC AND OCEANIA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: PACIFIC AND OCEANIA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 65: AFRICA: BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 66: AFRICA: BIOLOGICS SAFETY TESTING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 7: BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: BIOLOGICS SAFETY TESTING MARKET TO REGISTER A HIGH, DOUBLE-DIGIT GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 11: KITS & REAGENTS SEGMENT TO DOMINATE THE BIOLOGICS SAFETY TESTING MARKET IN 2017
  • FIGURE 12: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 13: VACCINE AND THERAPEUTICS DEVELOPMENT WILL CONTINUE TO DOMINATE THE BIOLOGICS SAFETY TESTING MARKET 2022
  • FIGURE 14: BIOLOGICS SAFETY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 15: KITS & REAGENTS SEGMENT TO DOMINATE THE BIOLOGICS SAFETY TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: ENDOTOXIN TESTS SEGMENT TO DOMINATE THE BIOLOGICS SAFETY TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: VACCINE & THERAPEUTICS DEVELOPMENT TO DOMINATE THE BIOLOGICS SAFETY TESTING MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO DOMINATE THE BIOLOGICS SAFETY TESTING MARKET IN 2017
  • FIGURE 19: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2017-2022)
  • FIGURE 20: U.S. TO WITNESS THE HIGHEST GROWTH RATE IN THE NORTH AMERICAN BIOLOGICS SAFETY TESTING MARKET DURING THE FORECAST PERIOD (2017-2022)
  • FIGURE 21: NORTH AMERICA: BIOLOGICS SAFETY TESTING MARKET SNAPSHOT
  • FIGURE 22: GERMANY TO WITNESS THE HIGHEST GROWTH RATE IN THE EUROPEAN BIOLOGICS SAFETY TESTING MARKET DURING THE FORECAST PERIOD (2017-2022)
  • FIGURE 23: ASIA: BIOLOGICS SAFETY TESTING MARKET, BY COUNTRY (2017)
  • FIGURE 24: ASIA: BIOLOGICS SAFETY TESTING MARKET SNAPSHOT
  • FIGURE 25: REST OF THE WORLD: BIOLOGICS SAFETY TESTING MARKET, BY REGION (2017)
  • FIGURE 26: BIOLOGICS SAFETY TESTING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 27: BIOLOGICS SAFETY TESTING MARKET: MARKET SHARE (2016)
  • FIGURE 28: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 29: MERCK KGAA: COMPANY SNAPSHOT (2016)
  • FIGURE 30: LONZA GROUP LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 31: SGS S.A.: COMPANY SNAPSHOT (2016)
  • FIGURE 32: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 33: SARTORIUS AG: COMPANY SNAPSHOT (2016)
  • FIGURE 34: EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2016)
  • FIGURE 35: SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2015)
Back to Top